Investors Press Releases Press Releases Details

Press Releases Details

View all news

WellPoint Reports Strong Second Quarter 2006 Results

July 26, 2006

Click here for printer-friendly version

* Net income was $1.17 per share, including net realized investment losses of $0.01 per share, exceeding previous expectations * With stable benefit expense ratios, pre-tax margin increased to 8.5 percent * The Company repurchased 23.3 million shares of its common stock during the second quarter for $1.7 billion * Full year 2006 earnings guidance raised to $4.74 per share, including net realized investment losses of $0.02 per share

INDIANAPOLIS, July 26, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- WellPoint, Inc. (NYSE: WLP) today announced that second quarter 2006 net income was $751.2 million, or $1.17 per share, including costs of $0.05 per share for the impact of expensing stock options in accordance with FAS 123R and net realized investment losses of $0.01 per share. Net income for the second quarter of 2005 was $559.4 million, or $0.90 per share, which included expenses of $0.10 per share related to an agreement resolving two national multi-district lawsuits with physicians.

"We are very pleased with our strong second quarter results that reinforce the very high expectations we set for ourselves at the beginning of the year," said Larry C. Glasscock, chairman, president and chief executive officer of WellPoint, Inc. "From a financial perspective, earnings per share growth was very strong, administrative costs as a percentage of revenue continued to improve and our medical expense ratio declined compared to the first quarter. We also introduced several new products and services that will further engage consumers in managing their health care, and offer more benefit options to our diverse customer base. During the second half of 2006, we expect continued membership growth, but not at the expense of profitability."

"We have used the excellent cash flow in the first six months of 2006 to improve equity returns," said David C. Colby, executive vice president and chief financial officer of WellPoint, Inc. "During the second quarter, we repurchased 23.3 million shares of our common stock for $1.7 billion. With Board approval of an additional $1.0 billion in share repurchase authorization during the quarter, we repurchased a total of 48.0 million shares for $3.6 billion through the first half of 2006. As expected, our year-to-date operating cash flow reached $2.0 billion and we continue to expect that full year 2006 operating cash flow will exceed $4.0 billion."

"With this second quarter earnings release, we are providing a Reconciliation of Medical Claims Payable," added Colby. "The magnitude of positive prior period development continues to reflect the conservative and consistent nature of our reserving processes."

COMPARABLE BASIS INFORMATION

On December 28, 2005, WellPoint, Inc. acquired WellChoice, Inc. For accounting purposes, the transaction was assumed to have closed on December 31, 2005. Accordingly, operations of the former WellChoice, Inc. are included in reported financial results for 2006. However, operations of the former WellChoice, Inc. are not included in reported financial results for 2005.

Unless otherwise indicated, the analysis in this press release compares reported financial results and does not adjust results for the effects of this acquisition. In certain areas, we have included "comparable basis" analyses that we believe provide more meaningful comparisons between periods, due to the inclusion of operations of the former WellChoice, Inc. in the comparable historical results. The "comparable basis" information is not calculated in accordance with U.S. generally accepted accounting principles ("GAAP") and is not intended to represent or be indicative of the results that WellPoint, Inc. would have reported had the acquisition been completed as of the dates presented, and should not be taken as representative or indicative of our future results. The methodologies for calculating the comparable basis information are either described within the text of the press release, or in the tables at the end of the press release where such comparable basis information is reconciled to WellPoint, Inc.'s reported GAAP financial results.

CONSOLIDATED HIGHLIGHTS

Membership: Medical enrollment totaled 34.2 million members at June 30, 2006, an increase of more than 5.3 million members from 28.8 million at June 30, 2005, including approximately 4.8 million members acquired through the WellChoice transaction.

On a comparable basis, enrollment increased by 616,000 members since June 30, 2005. Each of the Company's geographic regions increased by more than 100,000 members, as consumers continue to be attracted to WellPoint's expansive, cost-effective provider networks, superior customer service and leading health improvement and wellness programs. From a customer segment perspective, the increase in membership was driven by growth of 726,000 members in the National business and 102,000 members in State Sponsored operations. Growth was also realized in the Individual and Small Group ("ISG") and Senior businesses, while Large Group enrollment declined primarily due to the previously-announced losses of 377,000 members in the states of Georgia and Kentucky accounts.

Medical enrollment remained relatively flat during the second quarter of 2006. Fully-insured enrollment increased by 22,000 members despite in-group enrollment declines in the automotive industry. Self-funded enrollment declined sequentially due to the discontinuation of a rental network in Texas, resulting in the loss of 67,000 members.

Medicare Part D enrollment exceeded 1.5 million members as of June 30, 2006, as the Company added approximately 230,000 members during the second quarter.

Operating Revenue: Operating revenue exceeded $13.9 billion in the second quarter of 2006, an increase of 26.9 percent from approximately $11.0 billion in the prior year quarter.

On a comparable basis, second quarter 2006 operating revenue increased by $1.3 billion, or 10.5 percent, versus $12.6 billion in the prior year period. The increase resulted primarily from disciplined pricing, the addition of the New York state prescription drug contract and enrollment in the Company's Medicare Part D products.

Benefit Expense Ratio: The benefit expense ratio was 81.2 percent in the second quarter of 2006, a 50 basis point increase compared with 80.7 percent in the second quarter of 2005.

On a comparable basis, the benefit expense ratio declined by 10 basis points, from 81.3 percent in the second quarter of 2005. The overall 10 basis point decline resulted from a 30 basis point decline due to the non-recurrence of expenses related to the multi-district settlement agreement and a 20 basis point increase due primarily to year-over-year mix of business changes, including Medicare Part D and the New York state prescription drug contract.

The benefit expense ratio declined by 10 basis points sequentially, from 81.3 percent in the first quarter of 2006. Second quarter results included an improved benefit expense ratio for the Company's Medicare Part D products.

Premium and Cost Trends: Trends include Large Group and ISG fully-insured businesses.

For the rolling 12-month period ended June 30, 2006, the primary drivers of medical trend were outpatient and inpatient costs. Commercial premium yield for the same period exceeded total cost trend, where total cost trend included medical costs and selling, general and administrative ("SG&A") expense, resulting in an increase in underwriting margin. The Company continues to expect that full year 2006 medical cost trend will be less than 8.0 percent.

SG&A Expense Ratio: The SG&A expense ratio was 15.7 percent in the second quarter of 2006, a decrease of 100 basis points from 16.7 percent in the second quarter of 2005.

On a comparable basis, the SG&A expense ratio declined by 90 basis points, compared with 16.6 percent in the second quarter of 2005. The ratio improved year-over-year as the Company continued to control spending, spread administrative expenses across a growing revenue base and realize integration synergies and efficiencies.

The current quarter included costs for stock option expensing, which added approximately 40 basis points to the SG&A expense ratio. The second quarter 2005 ratio was unfavorably impacted by approximately 50 basis points as a result of the multi-district settlement agreement.

The SG&A expense ratio declined by 30 basis points compared with 16.0 percent in the first quarter of 2006, reflecting continued leveraging of overhead costs across a growing revenue base.

Operating Cash Flow: For the first six months of 2006, operating cash flow totaled $2.0 billion, or 1.3 times net income. Operating cash flow totaled $201.0 million in the second quarter, which was lower than the first quarter level due to two estimated income tax payments totaling $756.0 million that were made during the second quarter and the timing of CMS payments received during the first quarter.

Days in Claims Payable: Days in claims payable as of June 30, 2006, was 44.8 days, a decrease of 0.6 days from 45.4 days as of March 31, 2006. This decrease was primarily due to a further reduction in the length of time between the date of service and claim payment, and the timing of payments in the PBM operation.

Share Repurchase Program: During the second quarter 2006, the Company repurchased 23.3 million shares of its common stock for $1.7 billion. The Board of Directors increased the share repurchase authorization by $1.0 billion on May 16, 2006, to $4.0 billion in 2006. As of June 30, 2006, there was $399.6 million available under the Board's current repurchase authorization. Based on the current stock price and strong year-to-date financial results, the Company intends to utilize this remaining authorization during the third quarter of 2006, subject to market conditions. At June 30, 2006, cash and investments held at the parent company totaled $884.1 million.

REPORTABLE SEGMENTS

WellPoint, Inc. has three reportable segments: Health Care, Specialty and Other. Operating revenue and operating gain are the key measures used by management to evaluate performance in each segment.

                               WellPoint, Inc.
                        Reportable Segment Highlights
                                 (Unaudited)

     ($ In Millions)                            Three Months Ended June 30
                                               2006         2005     Change
     Operating Revenue
        Health Care                        $13,391.2    $10,474.9     27.8%
        Specialty                              880.4        752.6     17.0%
        Other:
           External Customers                  114.9         84.3     36.3%
           Intercompany Eliminations          (444.2)      (325.4)   (36.5%)
        Total Other                           (329.3)      (241.1)   (36.6%)
     Total Operating Revenue                13,942.3     10,986.4     26.9%

     Operating Gain (Loss)
        Health Care                         $1,060.6       $777.2     36.5%
        Specialty                              138.1         99.0     39.5%
        Other                                  (26.6)       (23.4)   (13.7%)


     ($ In Millions)                              Six Months Ended June 30
                                               2006         2005     Change
     Operating Revenue
        Health Care                        $26,449.1    $20,758.0     27.4%
        Specialty                            1,734.6      1,503.5     15.4%
        Other:
           External Customers                  231.3        172.4     34.2%
           Intercompany Eliminations          (858.0)      (642.1)   (33.6%)
        Total Other                           (626.7)      (469.7)   (33.4%)
     Total Operating Revenue                27,557.0     21,791.8     26.5%

     Operating Gain (Loss)
        Health Care                         $2,096.5     $1,633.9     28.3%
        Specialty                              251.7        193.4     30.1%
        Other                                  (40.6)       (70.9)    42.7%


Health Care: Operating gain for the Health Care segment was approximately $1.1 billion in the second quarter of 2006, an increase of 36.5 percent, compared with $777.2 million in the second quarter of 2005.

On a comparable basis, second quarter 2006 operating gain increased by $185.7 million, or 21.2 percent, versus $874.9 million in the prior year quarter. Performance in the Health Care segment improved year-over-year due to enrollment growth, disciplined underwriting and a focus on expense control, including benefits realized through integration initiatives. Operating gain in the second quarter 2006 included costs of $51.3 million for expensing stock options in accordance with FAS 123R, while the prior year quarter included expenses of $103.0 million related to the multi-district settlement agreement.

Specialty: Operating gain totaled $138.1 million in the second quarter of 2006, an increase of 39.5 percent compared with $99.0 million in the second quarter of 2005.

Second quarter 2006 operating gain increased by $39.2 million, or 39.6 percent, on a comparable basis, from $98.9 million in the prior year quarter. The increase resulted primarily from favorable experience in the life and disability lines of business. In addition, the Company continues to see growth in its on-going specialty operations.

OUTLOOK

Full Year 2006:

  • The Company now expects net income of $4.74 per share, including net realized investment losses of $0.02 per share. This estimate assumes the Company completes its remaining share repurchase authorization during the third quarter of 2006.
  • Operating revenue is expected to total approximately $56.4 billion.
  • The benefit expense ratio is expected to be approximately 80.9 percent.
  • The SG&A expense ratio is expected to be approximately 16.0 percent.
  • Operating cash flow is expected to exceed $4.0 billion.
  • Year-end medical enrollment is expected to be approximately 34.5 million members.

Third Quarter 2006:

 

  • The Company now expects net income of $1.22 per share in the third quarter.

Basis of Presentation

1. Operating gain is defined as operating revenue less benefit expense, selling expense, general and administrative expense, and cost of drugs. Operating gain is used to analyze profit or loss on a segment basis. Consolidated operating gain is a non-GAAP measure.

2. On December 28, 2005, WellPoint, Inc. acquired WellChoice, Inc. Accordingly, operations of the former WellChoice, Inc. are included in reported financial results for 2006. However, operations of the former WellChoice, Inc. are not included in reported financial results for 2005.

3. Amounts for 2005 and prior do not include the impact of expensing stock options in accordance with FAS 123R. The Company's 2006 reported results and its outlook for the remainder of 2006, however, do include this impact.

4. Certain prior period amounts have been reclassified to conform to current period presentation.

Conference Call and Webcast

Management will host a conference call and webcast today at 8:30 a.m. Eastern Daylight Time ("EDT") to discuss its second quarter earnings results and updated outlook. The conference call should be accessed at least 15 minutes prior to the start of the call with the following numbers:

888-423-3268 (Domestic) 800-475-6701 (Domestic Replay)

651-291-5254 (International) 320-365-3844 (International Replay)

An access code is not required for today's conference call. The access code for the replay is 831808. The replay will be available from 1:45 p.m. EDT today until the end of the day on August 9, 2006. The call will also be available through a live webcast at http://www.wellpoint.com under "Investor Info." A webcast replay will be available following the call.

About WellPoint, Inc.

WellPoint's mission is to improve the lives of the people it serves and the health of its communities. WellPoint, Inc. is the largest health benefits company in terms of commercial membership in the United States. Through its nationwide networks, the company delivers a number of leading health benefit solutions through a broad portfolio of integrated health care plans and related services, along with a wide range of specialty products such as life and disability insurance benefits, pharmacy benefit management, dental, vision, behavioral health benefit services, as well as long term care insurance and flexible spending accounts. Headquartered in Indianapolis, Indiana, WellPoint is an independent licensee of the Blue Cross and Blue Shield Association and serves its members as the Blue Cross licensee for California; the Blue Cross and Blue Shield licensee for Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri (excluding 30 counties in the Kansas City area), Nevada, New Hampshire, New York (as Blue Cross Blue Shield in 10 New York City metropolitan and surrounding counties and as Blue Cross or Blue Cross Blue Shield in selected upstate counties only), Ohio, Virginia (excluding the Northern Virginia suburbs of Washington, D.C.), Wisconsin; and through UniCare. Additional information about WellPoint is available at http://www.wellpoint.com .

                               WellPoint, Inc.
                Medical Membership & Specialty Metrics Summary
                         (Unaudited and in Thousands)

    Medical Membership
                                                                   As Reported
                                                        June 30,     June 30,
                                                         2006          2005
    Customer Type
    Large Group                                         15,959        13,220
    Individual and Small Group ("ISG")                   5,651         5,276

        National Accounts                                5,142         3,478
        BlueCard                                         4,194         4,000
    Total National                                       9,336         7,478

    Senior                                               1,246         1,065
    State Sponsored                                      1,971         1,804
    Total                                               34,163        28,843

    Funding Arrangement
    Self-Funded                                         16,980        14,420
    Fully-Insured                                       17,183        14,423
    Total                                               34,163        28,843

    Regional Membership
    East                                                13,779         8,723
    Central                                             11,051        10,997
    West                                                 9,333         9,123
    Total                                               34,163        28,843

    Specialty Metrics
    PBM Prescription Volume (2)                         96,919        84,437
    Behavioral Health Membership                        15,938        12,528
    Life and Disability Membership                       5,964         5,797
    Dental Membership                                    5,258         5,271
    Medicare Part D Membership (3)                       1,527             -
    Vision Membership                                      940           789


                                                     Comparable
                                                      Basis (1)
                                                       June 30,   December 31,
                                                         2005          2005
    Customer Type
    Large Group                                         16,242        16,362
    Individual and Small Group ("ISG")                   5,611         5,645

        National Accounts                                4,716         4,776
        BlueCard                                         3,894         3,915
    Total National                                       8,610         8,691

    Senior                                               1,215         1,224
    State Sponsored                                      1,869         1,934
    Total                                               33,547        33,856

    Funding Arrangement
    Self-Funded                                         16,238        16,584
    Fully-Insured                                       17,309        17,272
    Total                                               33,547        33,856

    Regional Membership
    East                                                13,672        13,800
    Central                                             10,871        10,970
    West                                                 9,004         9,086
    Total                                               33,547        33,856

    Specialty Metrics
    PBM Prescription Volume (2)                         84,437        91,813
    Behavioral Health Membership                        12,528        15,669
    Life and Disability Membership                       5,797         5,826
    Dental Membership                                    5,534         5,195
    Medicare Part D Membership (3)                           -             -
    Vision Membership                                      789           816


                                                            Change from
                                                      Comparable
                                                       Basis (1)
                                                        June 30,  December 31,
                                                          2005          2005
    Customer Type
    Large Group                                           (1.7%)        (2.5%)
    Individual and Small Group ("ISG")                     0.7%          0.1%

        National Accounts                                  9.0%          7.7%
        BlueCard                                           7.7%          7.1%
    Total National                                         8.4%          7.4%

    Senior                                                 2.6%          1.8%
    State Sponsored                                        5.5%          1.9%
    Total                                                  1.8%          0.9%

    Funding Arrangement
    Self-Funded                                            4.6%          2.4%
    Fully-Insured                                         (0.7%)        (0.5%)
    Total                                                  1.8%          0.9%

    Regional Membership
    East                                                   0.8%         (0.2%)
    Central                                                1.7%          0.7%
    West                                                   3.7%          2.7%
    Total                                                  1.8%          0.9%

    Specialty Metrics
    PBM Prescription Volume (2)                           14.8%          5.6%
    Behavioral Health Membership                          27.2%          1.7%
    Life and Disability Membership                         2.9%          2.4%
    Dental Membership                                     (5.0%)         1.2%
    Medicare Part D Membership (3)                           -             -
    Vision Membership                                     19.1%         15.2%



(1) "Comparable Basis" data was calculated by adding historical data for the former WellChoice, Inc. to WellPoint, Inc.'s historical data, and adjusting the combined totals to ensure a consistent approach for counting membership and to eliminate overlapping BlueCard host membership.

(2) Represents quarterly prescription volume at the Company's PBM operation.

(3) Includes auto-assigned, stand-alone, Medicare Advantage, group waiver and external PBM members with the prescription drug plan benefit.

                               WellPoint, Inc.
                      Consolidated Statements of Income
                                 (Unaudited)

    ($ In Millions, Except Per Share Data)   Three Months Ended
                                                  June 30
                                              2006        2005    Change
    Revenues
    Premiums                               $12,918.8   $10,196.8   26.7%
    Administrative fees                        877.1       664.2   32.1%
    Other revenue                              146.4       125.4   16.7%
        Total operating revenue             13,942.3    10,986.4   26.9%
    Net investment income                      218.5       159.8   36.7%
    Net realized (losses) gains on
     investments                                (8.9)        2.8     -
    Total revenues                          14,151.9    11,149.0   26.9%

    Expenses
    Benefit expense                         10,492.3     8,229.6   27.5%
    Selling, general and administrative
     expense
        Selling expense                        413.2       367.6   12.4%
        General and administrative
         expense                             1,778.9     1,465.3   21.4%
            Total selling, general and
             administrative expense          2,192.1     1,832.9   19.6%
    Cost of drugs                               85.8        71.1   20.7%
    Interest expense                           103.9        58.9   76.4%
    Amortization of other intangible
     assets                                     74.5        59.9   24.4%
    Total expenses                          12,948.6    10,252.4   26.3%

    Income before income taxes               1,203.3       896.6   34.2%

    Income taxes                               452.1       337.2   34.1%

    Net income                                $751.2      $559.4   34.3%

    Net income per diluted share               $1.17       $0.90   30.0%

    Diluted shares (in millions)               642.0       624.8    2.8%

    Benefit expense as a percentage of
     premiums                                  81.2%       80.7%      50 bp
    Selling, general and administrative
     expense as a percentage of total
     operating revenue                         15.7%       16.7%    (100)bp
    Income before income taxes as a
     percentage of total revenues               8.5%        8.0%      50 bp



                               WellPoint, Inc.
                      Consolidated Statements of Income
                                 (Unaudited)

    ($ In Millions, Except Per Share Data)    Six Months Ended
                                                  June 30
                                              2006        2005    Change
    Revenues
    Premiums                               $25,497.7   $20,212.7   26.1%
    Administrative fees                      1,761.1     1,324.9   32.9%
    Other revenue                              298.2       254.2   17.3%
        Total operating revenue             27,557.0    21,791.8   26.5%
    Net investment income                      430.6       298.5   44.3%
    Net realized (losses) gains on
     investments                               (16.0)        1.8     -
    Total revenues                          27,971.6    22,092.1   26.6%

    Expenses
    Benefit expense                         20,723.1    16,328.7   26.9%
    Selling, general and administrative
     expense
        Selling expense                        814.6       727.1   12.0%
        General and administrative
         expense                             3,550.1     2,834.9   25.2%
            Total selling, general and
             administrative expense          4,364.7     3,562.0   22.5%
    Cost of drugs                              161.6       144.7   11.7%
    Interest expense                           197.9       112.1   76.5%
    Amortization of other intangible
     assets                                    148.3       119.1   24.5%
    Total expenses                          25,595.6    20,266.6   26.3%

    Income before income taxes               2,376.0     1,825.5   30.2%

    Income taxes                               893.0       654.4   36.5%

    Net income                              $1,483.0    $1,171.1   26.6%

    Net income per diluted share               $2.26       $1.88   20.2%

    Diluted shares (in millions)               655.5       623.2    5.2%

    Benefit expense as a percentage of
     premiums                                  81.3%       80.8%      50 bp
    Selling, general and administrative
     expense as a percentage of total
     operating revenue                         15.8%       16.3%     (50)bp
    Income before income taxes as a
     percentage of total revenues               8.5%        8.3%      20 bp



                               WellPoint, Inc.
                         Consolidated Balance Sheets
                                                   June 30,       December 31,
    ($ In Millions)                                 2006              2005
                                                 (Unaudited)
    Assets
    Current assets:
       Cash and cash equivalents                  $1,934.4          $2,740.2
       Investments available-for-sale, at
        fair value                                 1,982.2           2,182.8
       Other invested assets, current                402.5             307.0
       Accrued investment income                     156.2             156.8
       Premiums and self-funded
        receivables                                2,360.6           2,216.4
       Other receivables                           1,148.9             831.4
       Securities lending collateral                 703.7           1,389.9
       Deferred tax assets, net                      728.8             689.0
       Other current assets                        1,167.8           1,022.7
    Total current assets                          10,585.1          11,536.2

    Long-term investments available-for-
     sale, at fair value                          14,843.9          14,898.2
    Other invested assets, long-term                 250.9             207.8
    Property and equipment, net                    1,014.9           1,078.6
    Goodwill                                      13,449.2          13,469.1
    Other intangible assets                        9,538.1           9,686.4
    Other noncurrent assets                          409.7             410.9
    Total assets                                 $50,091.8         $51,287.2
    Liabilities and shareholders' equity
    Liabilities
    Current liabilities:
       Policy liabilities:
         Medical claims payable                   $5,162.6          $4,853.4
         Reserves for future policy
          benefits                                    82.1              82.1
         Other policyholder liabilities            1,928.5           1,752.3
       Total policy liabilities                    7,173.2           6,687.8
       Unearned income                             1,596.5           1,057.1
       Accounts payable and accrued
        expenses                                   2,656.4           2,860.4
       Income taxes payable                          729.9             833.4
       Security trades pending payable                 9.3             181.8
       Securities lending payable                    703.7           1,389.9
       Current portion of long-term debt              22.4             481.2
       Other current liabilities                   1,451.3           1,286.8
    Total current liabilities                     14,342.7          14,778.4
    Long-term debt, less current portion           7,446.4           6,324.7
    Reserves for future policy benefits,
     noncurrent                                      653.3             679.9
    Deferred tax liability, net                    3,083.5           3,267.1
    Other noncurrent liabilities                   1,328.1           1,244.0
    Total liabilities                             26,854.0          26,294.1
    Shareholders' equity
    Common stock                                       6.2               6.6
    Additional paid-in capital                    19,846.3          20,915.4
    Retained earnings                              3,581.5           4,173.5
    Unearned stock compensation                        -               (82.1)
    Accumulated other comprehensive loss            (196.2)            (20.3)
    Total shareholders' equity                    23,237.8          24,993.1
    Total liabilities and shareholders'
     equity                                      $50,091.8         $51,287.2


                               WellPoint, Inc.
                    Consolidated Statements of Cash Flows
                                 (Unaudited)

                                                     Six Months Ended June 30
    ($ In Millions)                                   2006               2005
    Operating activities
    Net income                                    $1,483.0           $1,171.1
    Adjustments to reconcile net income
     to net cash provided by operating
     activities:
            Net realized losses (gains)
             on investments                           16.0               (1.8)
            Loss on disposal of assets                 0.9                0.2
            Deferred income taxes                    (40.5)             (45.0)
            Amortization, net of
             accretion                               230.1              224.7
            Depreciation                              68.5               59.5
            Share-based compensation                 141.1               36.3
            Excess tax benefits from
             share-based compensation                (62.4)               -
            Changes in operating assets
             and liabilities, net of
             effect of business
             combinations:
                    Receivables, net                (467.6)             (78.8)
                    Other invested
                     assets, current                 (95.2)               -
                    Other assets                    (142.3)             (48.8)
                    Policy liabilities               468.8               95.7
                    Unearned income                  539.4                6.0
                    Accounts payable and
                     accrued expenses               (304.0)             135.6
                    Other liabilities                181.2             (253.0)
                    Income taxes                     (18.4)             289.6
    Net cash provided by operating
     activities                                    1,998.6            1,591.3

    Investing activities
    Purchases of investments                      (9,517.9)         (10,011.3)
    Proceeds from sales and maturities of
     investments                                   9,255.5            9,382.4
    Changes in securities lending
     collateral                                      686.2              (77.3)
    Purchases of subsidiaries, net of
     cash acquired                                     -               (312.6)
    Payment for settlement of cash flow
     hedge                                           (24.7)               -
    Purchases of property and equipment              (72.8)             (85.6)
    Proceeds from sales of property and
     equipment                                         -                  6.7
    Net cash provided by (used in)
     investing activities                            326.3           (1,097.7)

    Financing activities
    Net proceeds from commercial paper
     borrowings                                      191.5              202.4
    Proceeds from long-term borrowings             2,668.9                -
    Repayment of long-term borrowings             (2,156.7)               -
    Changes in securities lending payable           (686.2)              77.3
    Changes in bank overdrafts                       124.0             (226.7)
    Repurchase and retirement of common
     stock                                        (3,600.4)            (333.4)
    Proceeds from exercise of employee
     stock options and employee stock purchase
     plan                                            265.8              281.8
    Proceeds from sale of put options                  -                  1.1
    Excess tax benefits from share-based
     compensation                                     62.4                -
    Net cash (used in) provided by
     financing activities                         (3,130.7)               2.5

    Change in cash and cash equivalents             (805.8)             496.1
    Cash and cash equivalents at
     beginning of period                           2,740.2            1,457.2
    Cash and cash equivalents at end of
     period                                       $1,934.4           $1,953.3



                               WellPoint, Inc.
                   Reconciliation of Medical Claims Payable

                                                            Six Months Ended
                                                                June 30
    ($ In Millions)                                         2006        2005
                                                               (Unaudited)

    Gross medical claims payable, beginning of period   $4,853.4    $4,134.0
    Ceded medical claims payable, beginning of period      (27.7)      (31.9)
    Net medical claims payable, beginning of period      4,825.7     4,102.1

    Business combinations and purchase adjustments          (6.4)          -

    Net incurred medical claims:
        Current year                                    21,156.8    16,671.0
        Prior years (redundancies) (1)                    (556.7)     (571.0)
    Total net incurred medical claims                   20,600.1    16,100.0

    Net payments attributable to:
        Current year medical claims                     16,534.4    12,934.0
        Prior years medical claims                       3,752.1     3,083.1
    Total net payments                                  20,286.5    16,017.1

    Net medical claims payable, end of period            5,132.9     4,185.0
    Ceded medical claims, end of period                     29.7        36.5
    Gross medical claims payable, end of period         $5,162.6    $4,221.5

    Current year medical claims paid as a percent of
        current year net incurred medical claims            78.2%       77.6%

    Prior year redundancies in the current period as
     a percent of prior year net medical claims
     payables less prior year redundancies in the
     current period                                         13.0%       16.2%

    Prior year redundancies in the current period as
     a percent of prior year net incurred medical
     claims - as reported (3)                                1.7%        3.7%

    Prior year redundancies in the current period as
     a percent of prior year net incurred medical
     claims - adjusted for acquisitions (3)                  1.5%        1.9%


                                                   Year Ended December 31
    ($ In Millions)                              2005       2004       2003


    Gross medical claims payable, beginning
     of period                                 $4,134.0   $1,836.0   $1,797.3
    Ceded medical claims payable, beginning
     of period                                    (31.9)      (8.7)      (2.8)
    Net medical claims payable, beginning of
     period                                     4,102.1    1,827.3    1,794.5

    Business combinations and purchase
     adjustments                                  784.5    2,331.0      (20.6)

    Net incurred medical claims:
        Current year                           32,865.6   15,344.9   12,316.7
        Prior years (redundancies) (1)           (644.9)    (171.9)    (225.9)
    Total net incurred medical claims          32,220.7   15,173.0   12,090.8

    Net payments attributable to:
        Current year medical claims            28,997.1   12,453.2   10,546.5
        Prior years medical claims              3,284.5    2,776.0    1,490.9
    Total net payments                         32,281.6   15,229.2   12,037.4

    Net medical claims payable, end of period   4,825.7    4,102.1    1,827.3
    Ceded medical claims, end of period            27.7       31.9        8.7
    Gross medical claims payable, end of
     period                                    $4,853.4   $4,134.0   $1,836.0

    Current year medical claims paid as a
     percent of current year net incurred
     medical claims                                88.2%      81.2%(2)   85.6%

    Prior year redundancies in the current
     period as a percent of prior year net
     medical claims payables less prior year
     redundancies in the current period            18.7%      10.4%      14.4%

    Prior year redundancies in the current
     period as a percent of prior year net
     incurred medical claims - as reported (3)      4.2%       1.4%       2.3%

    Prior year redundancies in the current
     period as a percent of prior year net
     incurred medical claims - adjusted for
     acquisitions (3)                               2.1%       1.4%       2.0%


(1) Negative amounts reported for net incurred medical claims related to prior years result from claims being settled for amounts less than originally estimated.

(2) This ratio is impacted by having only one month of net incurred medical claims and payments for the former WellPoint Health Networks Inc. ("WHN") in 2004. If WHN had not been included in 2004, current year medical claims paid would have been $12,057.7 million, current year net incurred medical claims would have been $13,835.1 million and the adjusted ratio would have been 87.2%.

(3) For all periods presented, except for the year ended December 31, 2004, the reported ratio of prior year redundancies in the current period to prior year net incurred medical claims is impacted by certain acquisitions (the former WellChoice, Inc. in 2005, WHN in 2004 and the former Trigon Healthcare, Inc. in 2002). The Company has provided ratios adjusted for these acquisitions in order to demonstrate these impacts. Refer to the table entitled, "Reconciliation of Medical Claims Payable - Adjusted Ratios" for details regarding the respective calculation methodologies.

                               WellPoint, Inc.
          Reconciliation of Medical Claims Payable - Adjusted Ratios
                                 (Unaudited)

Note: Below are reconciliations for the adjusted ratios of prior year redundancies in the current period to prior year net incurred medical claims that are included in table entitled, "Reconciliation of Medical Claims Payable."

    Ratio for the Six Months Ended June 30, 2006
    This ratio is impacted by having no net incurred medical claims for the
    former WellChoice, Inc. ("WC") in 2005.

           Net incurred medical claims related to prior years
            (redundancies) - six months ended June 30, 2006
            (As Reported)                                              $556.7

           Net incurred medical claims - year ended December 31,
            2005 (As Reported)                                      $32,865.6
                    Ratio (As Reported)                                   1.7%

           Net incurred medical claims - year ended December 31,
            2005 (Comparable Basis) (1)                             $37,676.0
                Ratio (As Adjusted)                                       1.5%

           (1)  Represents comparable benefit expense, assuming WC had been
                owned for the entire year ended December 31, 2005.


    Ratio for the Six Months Ended June 30, 2005
    This ratio is impacted by having only one month of net incurred medical
    claims for the former WellPoint Health Networks Inc. ("WHN") in 2004.

           Net incurred medical claims related to prior years
            (redundancies) - six months ended June 30, 2005
            (As Reported)                                              $571.0

           Net incurred medical claims - year ended December 31,
            2004 (As Reported)                                      $15,344.9
                Ratio (As Reported)                                       3.7%

           Net incurred medical claims - year ended December 31,
            2004 (Comparable Basis) (2)                             $30,819.1
                Ratio (As Adjusted)                                       1.9%

           (2)  Represents comparable benefit expense, assuming WHN had been
                owned for the entire year ended December 31, 2004.


    Ratio for the Year Ended December 31, 2005
    This ratio is impacted by having only one month of net incurred medical
    claims for WHN in 2004.

           Net incurred medical claims related to prior years
            (redundancies) - year ended December 31, 2005
            (As Reported)                                              $644.9

           Net incurred medical claims - year ended December 31,
            2004 (As Reported)                                      $15,344.9
                Ratio (As Reported)                                       4.2%

           Net incurred medical claims - year ended December 31,
            2004 (Comparable Basis) (3)                             $30,819.1
                Ratio (As Adjusted)                                       2.1%

           (3)  Represents comparable benefit expense, assuming WHN had been
                owned for the entire year ended December 31, 2004.


    Ratio for the Year Ended December 31, 2003
    This ratio is impacted by having only five months of net incurred medical
    claims for the former Trigon Healthcare, Inc. ("TGH") in 2002.

           Net incurred medical claims related to prior years
            (redundancies) - year ended December 31, 2003
            (As Reported)                                              $225.9

           Net incurred medical claims - year ended December 31,
            2002 (As Reported)                                       $9,838.5
                Ratio (As Reported)                                       2.3%

           Net incurred medical claims - year ended December 31,
            2002 (Comparable Basis) (4)                             $11,057.8
                Ratio (As Adjusted)                                       2.0%

           (4)  Represents comparable benefit expense, assuming TGH had been
                owned for the entire year ended December 31, 2002.


                               WellPoint, Inc.
             Selected Financial Data - Comparable Basis Analysis
                                 (Unaudited)

    ($ In Millions)                                   As Reported
                                              Three Months Ended June 30
                                             2006         2005      % Change
    Revenues
    Premiums                                $12,918.8    $10,196.8    26.7%
    Administrative fees                         877.1        664.2    32.1%
    Other revenue                               146.4        125.4    16.7%
        Total operating revenue              13,942.3     10,986.4    26.9%

    Expenses
    Benefit expense                          10,492.3      8,229.6    27.5%
    Selling, general and administrative
     expense
        Selling expense                         413.2        367.6    12.4%
        General and administrative
         expense                              1,778.9      1,465.3    21.4%
            Total selling, general and
             administrative expense           2,192.1      1,832.9    19.6%
    Cost of drugs                                85.8         71.1    20.7%

    Benefit expense as a percentage of
     premiums                                   81.2%        80.7%       50 bp
    Selling, general and administrative
     expense as a percentage of total
     operating revenue                          15.7%        16.7%     (100)bp



    ($ In Millions)                              Comparable Basis (1)
                                              Three Months Ended June 30
                                             2005       $ Change    % Change
    Revenues
    Premiums                                $11,683.4    $1,235.4    10.6%
    Administrative fees                         807.9        69.2     8.6%
    Other revenue                               125.3        21.1    16.8%
        Total operating revenue              12,616.6     1,325.7    10.5%

    Expenses
    Benefit expense                           9,497.1       995.2    10.5%
    Selling, general and administrative
     expense
        Selling expense                         386.6        26.6     6.9%
        General and administrative
         expense                              1,713.3        65.6     3.8%
            Total selling, general and
             administrative expense           2,099.9        92.2     4.4%
    Cost of drugs                                71.1        14.7    20.7%

    Benefit expense as a percentage of
     premiums                                   81.3%                  (10)bp
    Selling, general and administrative
     expense as a percentage of total
     operating revenue                          16.6%                  (90)bp



    ($ In Millions)                                   As Reported
                                               Six Months Ended June 30
                                             2006         2005      % Change
    Revenues
    Premiums                                $25,497.7    $20,212.7    26.1%
    Administrative fees                       1,761.1      1,324.9    32.9%
    Other revenue                               298.2        254.2    17.3%
        Total operating revenue              27,557.0     21,791.8    26.5%

    Expenses
    Benefit expense                          20,723.1     16,328.7    26.9%
    Selling, general and administrative
     expense
        Selling expense                         814.6        727.1    12.0%
        General and administrative
         expense                              3,550.1      2,834.9    25.2%
            Total selling, general and
             administrative expense           4,364.7      3,562.0    22.5%
    Cost of drugs                               161.6        144.7    11.7%

    Benefit expense as a percentage of
     premiums                                   81.3%        80.8%       50 bp
    Selling, general and administrative
     expense as a percentage of total
     operating revenue                          15.8%        16.3%      (50)bp



    ($ In Millions)                              Comparable Basis (1)
                                               Six Months Ended June 30
                                             2005       $ Change    % Change
    Revenues
    Premiums                                $23,064.8    $2,432.9    10.5%
    Administrative fees                       1,628.5       132.6     8.1%
    Other revenue                               254.0        44.2    17.4%
        Total operating revenue              24,947.3     2,609.7    10.5%

    Expenses
    Benefit expense                          18,777.1     1,946.0    10.4%
    Selling, general and administrative
     expense
        Selling expense                         763.3        51.3     6.7%
        General and administrative
         expense                              3,314.2       235.9     7.1%
            Total selling, general and
             administrative expense           4,077.5       287.2     7.0%
    Cost of drugs                               144.7        16.9    11.7%

    Benefit expense as a percentage of
     premiums                                   81.4%                  (10)bp
    Selling, general and administrative
     expense as a percentage of total
     operating revenue                          16.3%                  (50)bp


(1) The "Comparable Basis" information is a non-GAAP measure. Refer to the tables entitled, "Reclassified Consolidated Statements of Income - Comparable Basis Reconciliation."

                               WellPoint, Inc.
          Reportable Segment Highlights - Comparable Basis Analysis
                                 (Unaudited)

    ($ In Millions)                                  As Reported
                                             Three Months Ended June 30
                                             2006        2005     % Change
    Operating Revenue
      Health Care Segment                  $13,391.2   $10,474.9    27.8%
      Specialty Segment                        880.4       752.6    17.0%
      Other Segment                           (329.3)     (241.1)  (36.6%)
    Total Operating Revenue                 13,942.3    10,986.4    26.9%

    Operating Gain (Loss)
      Health Care Segment                   $1,060.6      $777.2    36.5%
      Specialty Segment                        138.1        99.0    39.5%
      Other Segment                            (26.6)      (23.4)  (13.7%)

    Operating Margin (2)
      Health Care Segment                       7.9%        7.4%       50 bp
      Specialty Segment                        15.7%       13.2%      250 bp



    ($ In Millions)                             Comparable Basis (1)
                                             Three Months Ended June 30
                                             2005     $ Change    % Change
    Operating Revenue
      Health Care Segment                  $12,064.2   $1,327.0    11.0%
      Specialty Segment                        760.3      120.1    15.8%
      Other Segment                           (207.9)    (121.4)  (58.4%)
    Total Operating Revenue                 12,616.6    1,325.7    10.5%

    Operating Gain (Loss)
      Health Care Segment                     $874.9     $185.7    21.2%
      Specialty Segment                         98.9       39.2    39.6%
      Other Segment                            (25.3)      (1.3)   (5.1%)

    Operating Margin (2)
      Health Care Segment                       7.3%                  60 bp
      Specialty Segment                        13.0%                 270 bp



    ($ In Millions)                                  As Reported
                                              Six Months Ended June 30
                                             2006        2005     % Change
    Operating Revenue
      Health Care Segment                  $26,449.1   $20,758.0    27.4%
      Specialty Segment                      1,734.6     1,503.5    15.4%
      Other Segment                           (626.7)     (469.7)  (33.4%)
    Total Operating Revenue                 27,557.0    21,791.8    26.5%

    Operating Gain (Loss)
      Health Care Segment                   $2,096.5    $1,633.9    28.3%
      Specialty Segment                        251.7       193.4    30.1%
      Other Segment                            (40.6)      (70.9)   42.7%

    Operating Margin (2)
      Health Care Segment                       7.9%        7.9%        0 bp
      Specialty Segment                        14.5%       12.9%      160 bp



    ($ In Millions)                             Comparable Basis (1)
                                              Six Months Ended June 30
                                             2005     $ Change    % Change
    Operating Revenue
      Health Care Segment                  $23,830.3   $2,618.8    11.0%
      Specialty Segment                      1,519.5      215.1    14.2%
      Other Segment                           (402.5)    (224.2)  (55.7%)
    Total Operating Revenue                 24,947.3    2,609.7    10.5%

    Operating Gain (Loss)
      Health Care Segment                   $1,828.6     $267.9    14.7%
      Specialty Segment                        193.9       57.8    29.8%
      Other Segment                            (74.5)      33.9    45.5%

    Operating Margin (2)
      Health Care Segment                       7.7%                  20 bp
      Specialty Segment                        12.8%                 170 bp


(1) The "Comparable Basis" information is a non-GAAP measure. Refer to the tables entitled, "Reclassified Reportable Segment Highlights - Comparable Basis Reconciliation."

(2) Operating margin is calculated as operating gain as a percentage of operating revenue.

                               WellPoint, Inc.
      Reclassified Consolidated Statements of Income - Comparable Basis
                                Reconciliation
                                 (Unaudited)


                                       Three Months Ended June 30, 2005
    ($ In Millions)               WLP (1)                           WLP (1)
                              As Reported  Reclassifications (2)  Reclassified
    Revenues
    Premiums                    $10,332.9       $(136.1)           $10,196.8
    Administrative fees             667.8          (3.6)               664.2
    Other revenue (expense)         135.9         (10.5)               125.4
       Total operating revenue   11,136.6        (150.2)            10,986.4
    Net investment income           159.8             -                159.8
    Net realized gains on
     investments                      2.8             -                  2.8
    Total revenues               11,299.2        (150.2)            11,149.0

    Expenses
    Benefit expense               8,379.8        (150.2)             8,229.6
    Selling, general and
     administrative expense
       Selling expense              367.6             -                367.6
       General and administrative
        expense                   1,465.3             -              1,465.3
          Total selling, general
           and administrative
           expense                1,832.9             -              1,832.9
    Cost of drugs                    71.1             -                 71.1
    Interest expense                 58.9             -                 58.9
    Amortization of other
     intangible assets               59.9             -                 59.9
    Total expenses               10,402.6        (150.2)            10,252.4

    Income before income taxes      896.6             -                896.6
    Income taxes                    337.2             -                337.2

    Net income                     $559.4            $-               $559.4

    Benefit expense as a
     percentage of premiums          81.1%                              80.7%
    Selling, general and
     administrative expense as a
     percentage of total operating
     revenue                         16.5%                              16.7%



                                              Three Months Ended June 30, 2005
    ($ In Millions)                            WC (1)
                                            As Reported  Reclassifications (2)
    Revenues
    Premiums                                   $1,491.1            $(4.5)
    Administrative fees                           139.8              3.9
    Other revenue (expense)                        (0.1)             -
       Total operating revenue                  1,630.8             (0.6)
    Net investment income                          20.1              -
    Net realized gains on investments               3.0              -
    Total revenues                              1,653.9             (0.6)

    Expenses
    Benefit expense                             1,283.2            (15.7)
    Selling, general and administrative
     expense
       Selling expense                              -               19.0
       General and administrative
        expense                                   251.9             (3.9)
          Total selling, general and
           administrative expense                 251.9             15.1
    Cost of drugs                                   -                -
    Interest expense                                -                -
    Amortization of other intangible
     assets                                         -                -
    Total expenses                              1,535.1             (0.6)

    Income before income taxes                    118.8              -
    Income taxes                                   44.2              -

    Net income                                    $74.6              $-

    Benefit expense as a percentage of
     premiums                                      86.1%
    Selling, general and administrative
     expense as a
       percentage of total operating
        revenue                                    15.4%



                                             Three Months Ended June 30, 2005
    ($ In Millions)                            WC (1)        WellPoint, Inc.
                                            Reclassified  Comparable Basis (3)
    Revenues
    Premiums                                    $1,486.6          $11,683.4
    Administrative fees                            143.7              807.9
    Other revenue (expense)                         (0.1)             125.3
       Total operating revenue                   1,630.2           12,616.6
    Net investment income                           20.1              179.9
    Net realized gains on investments                3.0                5.8
    Total revenues                               1,653.3           12,802.3

    Expenses
    Benefit expense                              1,267.5            9,497.1
    Selling, general and administrative
     expense
       Selling expense                              19.0              386.6
       General and administrative expense          248.0            1,713.3
          Total selling, general and
           administrative expense                  267.0            2,099.9
    Cost of drugs                                      -               71.1
    Interest expense                                   -               58.9
    Amortization of other intangible
     assets                                            -               59.9
    Total expenses                               1,534.5           11,786.9

    Income before income taxes                     118.8            1,015.4
    Income taxes                                    44.2              381.4

    Net income                                     $74.6             $634.0

    Benefit expense as a percentage of
     premiums                                       85.3%              81.3%
    Selling, general and administrative
     expense as a percentage of total
     operating revenue                              16.4%              16.6%


    (1)  WLP = WellPoint, Inc.; WC = WellChoice, Inc.

(2) To reflect the reclassification of certain historical amounts to a consistent presentation format adopted by the combined organization. In connection with the acquisition of WellChoice, Inc., the Company adopted a consistent practice for reporting minimum premium amendments to fully-insured contracts throughout the combined enterprise.

(3) The "Comparable Basis" information was calculated by adding the reclassified consolidated statements of income for WellPoint, Inc. and the former WellChoice, Inc.

This "Comparable Basis" information contains no intercompany eliminations or pro forma adjustments resulting from WellPoint, Inc.'s acquisition of WellChoice, Inc.

"Comparable Basis" information is presented in order to provide investors with a more meaningful comparison to the current period, due to the acquisition of WellChoice, Inc.

"Comparable Basis" information is not calculated in accordance with GAAP and is not intended to represent or be indicative of the results that WellPoint, Inc. would have reported, had the acquisition been completed as of January 1, 2005.

                               WellPoint, Inc.
      Reclassified Consolidated Statements of Income - Comparable Basis
                                Reconciliation
                                 (Unaudited)


                                       Six Months Ended June 30, 2005
    ($ In Millions)              WLP (1)                             WLP (1)
                              As Reported  Reclassifications (2)  Reclassified
    Revenues
    Premiums                    $20,491.7        $(279.0)          $20,212.7
    Administrative fees           1,332.0           (7.1)            1,324.9
    Other revenue (expense)         275.1          (20.9)              254.2
       Total operating revenue   22,098.8         (307.0)           21,791.8
    Net investment income           298.5              -               298.5
    Net realized gains on
     investments                      1.8              -                 1.8
    Total revenues               22,399.1         (307.0)           22,092.1

    Expenses
    Benefit expense              16,635.7         (307.0)           16,328.7
    Selling, general and
     administrative expense
       Selling expense              727.1              -               727.1
       General and administrative
        expense                   2,834.9              -             2,834.9
          Total selling, general
           and administrative
           expense                3,562.0              -             3,562.0
    Cost of drugs                   144.7              -               144.7
    Interest expense                112.1              -               112.1
    Amortization of other
     intangible assets              119.1              -               119.1
    Total expenses               20,573.6         (307.0)           20,266.6

    Income before income taxes    1,825.5               -            1,825.5
    Income taxes                    654.4               -              654.4

    Net income                   $1,171.1              $-           $1,171.1

    Benefit expense as a
     percentage of premiums          81.2%                              80.8%
    Selling, general and
     administrative expense as a
     percentage of total operating
     revenue                         16.1%                              16.3%



                                              Six Months Ended June 30, 2005
    ($ In Millions)                            WC (1)
                                            As Reported  Reclassifications (2)
    Revenues
    Premiums                                   $2,876.2            $(24.1)
    Administrative fees                           281.1              22.5
    Other revenue (expense)                        (0.2)              -
       Total operating revenue                  3,157.1              (1.6)
    Net investment income                          37.9               -
    Net realized gains on investments               3.6               -
    Total revenues                              3,198.6              (1.6)

    Expenses
    Benefit expense                             2,480.5             (32.1)
    Selling, general and administrative
     expense
       Selling expense                              -                36.2
       General and administrative
        expense                                   485.0              (5.7)
          Total selling, general and
           administrative expense                 485.0              30.5
    Cost of drugs                                   -                 -
    Interest expense                                -                 -
    Amortization of other intangible
     assets                                         -                 -
    Total expenses                              2,965.5              (1.6)

    Income before income taxes                    233.1               -
    Income taxes                                   87.6               -

    Net income                                   $145.5               $-

    Benefit expense as a percentage of
     premiums                                     86.2%
    Selling, general and administrative
     expense as a percentage of total
     operating revenue                            15.4%



                                             Six Months Ended June 30, 2005
    ($ In Millions)                            WC (1)        WellPoint, Inc.
                                            Reclassified  Comparable Basis (3)
    Revenues
    Premiums                                    $2,852.1          $23,064.8
    Administrative fees                            303.6            1,628.5
    Other revenue (expense)                         (0.2)             254.0
       Total operating revenue                   3,155.5           24,947.3
    Net investment income                           37.9              336.4
    Net realized gains on investments                3.6                5.4
    Total revenues                               3,197.0           25,289.1

    Expenses
    Benefit expense                              2,448.4           18,777.1
    Selling, general and administrative
     expense
       Selling expense                              36.2              763.3
       General and administrative expense          479.3            3,314.2
          Total selling, general and
           administrative expense                  515.5            4,077.5
    Cost of drugs                                    -                144.7
    Interest expense                                 -                112.1
    Amortization of other intangible
     assets                                          -                119.1
    Total expenses                               2,963.9           23,230.5

    Income before income taxes                     233.1            2,058.6
    Income taxes                                    87.6              742.0

    Net income                                    $145.5           $1,316.6

    Benefit expense as a percentage of
     premiums                                       85.8%              81.4%
    Selling, general and administrative
     expense as a percentage of total
     operating revenue                              16.3%              16.3%


    (1)  WLP = WellPoint, Inc.; WC = WellChoice, Inc.

(2) To reflect the reclassification of certain historical amounts to a consistent presentation format adopted by the combined organization. In connection with the acquisition of WellChoice, Inc., the Company adopted a consistent practice for reporting minimum premium amendments to fully-insured contracts throughout the combined enterprise.

(3) The "Comparable Basis" information was calculated by adding the reclassified consolidated statements of income for WellPoint, Inc. and the former WellChoice, Inc.

This "Comparable Basis" information contains no intercompany eliminations or pro forma adjustments resulting from WellPoint, Inc.'s acquisition of WellChoice, Inc.

"Comparable Basis" information is presented in order to provide investors with a more meaningful comparison to the current period, due to the acquisition of WellChoice, Inc.

"Comparable Basis" information is not calculated in accordance with GAAP and is not intended to represent or be indicative of the results that WellPoint, Inc. would have reported, had the acquisition been completed as of January 1, 2005.

                               WellPoint, Inc.
        Reclassified Reportable Segment Highlights - Comparable Basis
                                Reconciliation
                                 (Unaudited)


                                       Three Months Ended June 30, 2005
    ($ In Millions)              WLP (1)                             WLP (1)
                              As Reported  Reclassifications (2)  Reclassified
    Operating Revenue (4)
    Health Care                 $10,663.8        $(188.9)          $10,474.9
    Specialty                       695.9           56.7               752.6
    Other                          (223.1)         (18.0)             (241.1)
    Commercial Managed Care             -              -                   -
    Other Insurance Products and
     Services                           -              -                   -
       Total operating revenue   11,136.6         (150.2)           10,986.4

    Operating Gain (Loss) (4)
    Health Care                     785.6           (8.4)              777.2
    Specialty                        92.1            6.9                99.0
    Other                           (24.9)           1.5               (23.4)
    Commercial Managed Care             -              -                   -
    Other Insurance Products and
     Services                           -              -                   -



                                             Three Months Ended June 30, 2005
    ($ In Millions)                            WC (1)
                                            As Reported  Reclassifications (2)
    Operating Revenue (4)
    Health Care                                     $-            $1,589.3
    Specialty                                        -                 7.7
    Other                                            -                33.2
    Commercial Managed Care                     1,402.7           (1,402.7)
    Other Insurance Products and Services         228.1             (228.1)
       Total operating revenue                  1,630.8               (0.6)

    Operating Gain (Loss) (4)
    Health Care                                     -                 97.7
    Specialty                                       -                 (0.1)
    Other                                           -                 (1.9)
    Commercial Managed Care                        60.4              (60.4)
    Other Insurance Products and Services          35.3              (35.3)



                                            Three Months Ended June 30, 2005
    ($ In Millions)                            WC (1)        WellPoint, Inc.
                                            Reclassified  Comparable Basis (3)
    Operating Revenue (4)
    Health Care                                 $1,589.3          $12,064.2
    Specialty                                        7.7              760.3
    Other                                           33.2             (207.9)
    Commercial Managed Care                          -                  -
    Other Insurance Products and Services            -                  -
       Total operating revenue                   1,630.2           12,616.6

    Operating Gain (Loss) (4)
    Health Care                                     97.7              874.9
    Specialty                                       (0.1)              98.9
    Other                                           (1.9)             (25.3)
    Commercial Managed Care                          -                  -
    Other Insurance Products and Services            -                  -



                                       Six Months Ended June 30, 2005
    ($ In Millions)               WLP (1)                            WLP (1)
                              As Reported  Reclassifications (2)  Reclassified
    Operating Revenue (4)
    Health Care                 $21,140.2        $(382.2)         $20,758.0
    Specialty                     1,391.3          112.2            1,503.5
    Other                          (432.7)         (37.0)            (469.7)
    Commercial Managed Care             -              -                  -
    Other Insurance Products and
     Services                           -              -                  -
       Total operating revenue   22,098.8         (307.0)          21,791.8

    Operating Gain (Loss) (4)
    Health Care                   1,646.2          (12.3)           1,633.9
    Specialty                       183.8            9.6              193.4
    Other                           (73.6)           2.7              (70.9)
    Commercial Managed Care             -              -                  -
    Other Insurance Products and
     Services                           -              -                  -


                                              Six Months Ended June 30, 2005
    ($ In Millions)                            WC (1)
                                            As Reported  Reclassifications (2)
    Operating Revenue (4)
    Health Care                                     $-            $3,072.3
    Specialty                                        -                16.0
    Other                                            -                67.2
    Commercial Managed Care                     2,702.5           (2,702.5)
    Other Insurance Products and Services         454.6             (454.6)
       Total operating revenue                  3,157.1               (1.6)

    Operating Gain (Loss) (4)
    Health Care                                     -                194.7
    Specialty                                       -                  0.5
    Other                                           -                 (3.6)
    Commercial Managed Care                       146.0             (146.0)
    Other Insurance Products and Services          45.6              (45.6)


                                             Six Months Ended June 30, 2005
    ($ In Millions)                            WC (1)        WellPoint, Inc.
                                            Reclassified  Comparable Basis (3)
    Operating Revenue (4)
    Health Care                                 $3,072.3          $23,830.3
    Specialty                                       16.0            1,519.5
    Other                                           67.2             (402.5)
    Commercial Managed Care                          -                  -
    Other Insurance Products and Services            -                  -
       Total operating revenue                   3,155.5           24,947.3

    Operating Gain (Loss) (4)
    Health Care                                    194.7            1,828.6
    Specialty                                        0.5              193.9
    Other                                           (3.6)             (74.5)
    Commercial Managed Care                          -                  -
    Other Insurance Products and Services            -                  -


    (1)  WLP = WellPoint, Inc.; WC = WellChoice, Inc.

(2) To reflect the reclassification of certain historical amounts to a consistent presentation format adopted by the combined organization. In connection with the acquisition of WellChoice, Inc., the Company adopted a consistent practice for reporting minimum premium amendments to fully-insured contracts throughout the combined enterprise.

(3) The "Comparable Basis" information was calculated by adding the reclassified consolidated statements of income for WellPoint, Inc. and the former WellChoice, Inc.

This "Comparable Basis" information contains no intercompany eliminations or pro forma adjustments resulting from WellPoint, Inc.'s acquisition of WellChoice, Inc.

"Comparable Basis" information is presented in order to provide investors with a more meaningful comparison to the current period, due to the acquisition of WellChoice, Inc.

"Comparable Basis" information is not calculated in accordance with GAAP and is not intended to represent or be indicative of the results that WellPoint, Inc. would have reported, had the acquisition been completed as of January 1, 2005.

(4) Operating revenue and operating gain are the key measures used by management to evaluate performance in each segment. Operating gain is defined as operating revenue less benefit expense, selling expense, general and administrative expense, and cost of drugs. Operating gain is used to analyze profit or loss on a segment basis.

    Consolidated operating gain is a non-GAAP measure.


              SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES
                        LITIGATION REFORM ACT OF 1995

This press release contains certain forward-looking information about WellPoint, Inc. ("WellPoint") that is intended to be covered by the safe harbor for "forward-looking statements" provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts. Words such as "expect(s)", "feel(s)", "believe(s)", "will", "may", "anticipate(s)" and similar expressions are intended to identify forward-looking statements. These statements include, but are not limited to, financial projections and estimates and their underlying assumptions; statements regarding plans, objectives and expectations with respect to future operations, products and services; and statements regarding future performance. Such statements are subject to certain risks and uncertainties, many of which are difficult to predict and generally beyond the control of WellPoint, that could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include: those discussed and identified in public filings with the U.S. Securities and Exchange Commission ("SEC") made by WellPoint and WellChoice, Inc. ("WellChoice"); trends in health care costs and utilization rates; our ability to secure sufficient premium rate increases; competitor pricing below market trends of increasing costs; increased government regulation of health benefits and managed care; significant acquisitions or divestitures by major competitors; introduction and utilization of new prescription drugs and technology; a downgrade in our financial strength ratings; litigation and investigations targeted at health benefits companies and our ability to resolve litigation and investigations within estimates; our ability to contract with providers consistent with past practice; other potential uses of cash in the future that present attractive alternatives to share repurchases; our ability to achieve expected synergies and operating efficiencies in the WellPoint Health Networks Inc. merger and WellChoice acquisition within the expected time-frames or at all and to successfully integrate our operations; such integration may be more difficult, time-consuming or costly than expected; revenues following the transactions may be lower than expected; operating costs, customer loss and business disruption, including, without limitation, difficulties in maintaining relationships with employees, customers, clients or suppliers, may be greater than expected following the transactions; our ability to meet expectations regarding repurchases of shares of our common stock; our ability to meet expectations regarding the accounting and tax treatments of the transactions and the value of transaction consideration; future bio-terrorist activity or other potential public health epidemics; and general economic downturns. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof. WellPoint does not undertake any obligation to republish revised forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. Readers are also urged to carefully review and consider the various disclosures in WellPoint's and WellChoice's various SEC reports, including but not limited to WellPoint's Annual Report on Form 10-K for the year ended December 31, 2005, and its Quarterly Reports on Form 10-Q for the reporting periods of 2006.

SOURCE WellPoint, Inc.

Investor Relations: Wayne DeVeydt, +1-317-488-6390, or Media: James Kappel, +1-317-488-6400, both of WellPoint, Inc.

Multimedia Files:

View all news